434 Updated clinical data from the melanoma expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab

• Jennifer Roberts,
• Michael Postow,
• Ezra Cohen,
• Bartosz Chmielowski,
• Conor Steuer,
• Jerry McCarter,
• Nora Zizlsperger,
• Jeff Kutok,
• Brenda O’Connell,
• Kara Page,
• Halle Zhang

Affiliations

Jennifer Roberts

7Infinity Pharmaceuticals, Cambridge, MA, USA

Michael Postow

Aff1 grid.51462.340000000121719952Memorial Sloan Kettering Cancer Center New York NY USA

Ezra Cohen

Aff2 grid.420234.3UC San Diego Health System - La Jolla La Jolla Ca USA

Bartosz Chmielowski

Aff7 0000 0000 9632 6718grid.19006.3eJonsson Comprehensive Medical CenterUniversity of California Los Angeles, 10945 Le Conte Ave #2339 Los Angeles CA USA

Conor Steuer

6Emory University Hospital, Atlanta, GA, USA

Jerry McCarter

7Infinity Pharmaceuticals, Cambridge, MA, USA

Nora Zizlsperger

7Infinity Pharmaceuticals, Cambridge, MA, USA

Jeff Kutok

8Epizyme, Cambridge, MA, USA

Brenda O’Connell

7Infinity Pharmaceuticals, Cambridge, MA, USA

Kara Page

7Infinity Pharmaceuticals, Cambridge, MA, USA

Halle Zhang

9Infinity, Cambridge, MA, USA